Conditions : Inflammation; Rheumatoid Arthritis Interventions : Drug: NNC0109-0012; Drug: placebo Sponsor : Novo Nordisk Recruiting - verified November 2013

Conditions : Inflammation; Rheumatoid Arthritis Interventions : Drug: NNC0109-0012; Drug: placebo Sponsor : Novo Nordisk Recruiting - verified November 2013

Condition : Rheumatoid Arthritis Intervention : Sponsor : Hoffmann-La Roche Completed - verified November 2013

Condition : Arthritis, Rheumatoid Interventions : Drug: Sirukumab; Drug: Midazolam; Drug: Warfarin; Drug: Vitamin K; Drug: Omeprazole; Drug: Caffeine Sponsor : Janssen Research & Development, LLC Comp...

Condition : Rheumatoid Arthritis Interventions : Biological: Rituximab-Pfizer (PF-05280586) x 3 courses; Biological: Rituximab-EU+ Rituximab-Pfizer x 2 Courses; Biological: Rituximab-US + Rituximab-Pf...

The purpose of this study is to evaluate the long term safety and tolerability of fostamatinib in patients in Asia with rheumatoid arthritis (RA).

Condition : Osteoarthritis, Knee Intervention : Device: TKA with Journey II BCS Total Knee System Sponsors : Smith & Nephew, Inc.; Smith & Nephew, Inc. Recruiting - verified June 2013

Condition : Osteoarthritis Intervention : Behavioral: PainCOACH Sponsors : University of North Carolina, Chapel Hill; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Comp...

Condition : Osteoarthritis, Knee Intervention : Device: TKA with Journey II BCS Total Knee System Sponsor : Smith & Nephew, Inc. Recruiting - verified February 2014

Conditions : Degenerative Osteoarthritis; Defect of Articular Cartilage Interventions : Biological: CARTISTEM; Procedure: Microfracture Sponsors : Medipost Co Ltd.; Dong-A Pharmaceutical Co., Ltd. Rec...